期刊文献+

Epac1在胃癌组织中的表达及其临床意义

Expression and clinical significance of Epac1 in gastric cancer tissues
暂未订购
导出
摘要 目的探讨环磷酸腺苷活化交换蛋白1(Epac1)在胃癌组织中的表达及其临床意义。方法选择2016年1月1日至2016年12月31日在西南医科大学附属医院胃肠外科确诊并接受胃癌根治手术的65例患者,收集其胃癌组织、癌旁组织和正常组织标本。采用蛋白质印迹法检测胃癌组织、癌旁组织、正常组织,以及低分化、中分化、高分化胃癌组织中的Epac1蛋白表达水平。采用免疫组织化学染色法检测胃癌组织、癌旁组织和正常组织中Epac1表达情况;根据胃癌组织中Epac1表达情况将患者分为Epac1低表达组和Epac1高表达组,分析胃癌组织中不同Epac1表达与临床病理特征的关系。术后对65例胃癌患者进行随访,绘制Kaplan-Meier生存曲线以分析Epac1表达与预后的关系。结果胃癌组织中Epac1蛋白表达水平分别显著高于癌旁组织和正常组织(P均<0.01),低分化胃癌组织中Epac1蛋白表达水平分别显著高于中分化、高分化胃癌组织(P均<0.01)。胃癌组织中Epac1表达与肿瘤浸润深度、淋巴结转移、远处转移、血管侵犯、TNM分期、分化程度均有相关性(P均<0.05),而与患者的性别、年龄、肿瘤部位、肿瘤直径和肿瘤分型均无相关性(P均>0.05)。Kaplan-Meier生存曲线分析结果显示,Epac1高表达组术后3年的总生存率和无病生存率均显著低于Epac1低表达组(P均<0.05)。结论胃癌组织中Epac1表达显著上调,这与胃癌患者预后不良相关,提示Epac1可能参与了胃癌的发生和进展,其对胃癌患者预后有一定的预测价值。 Objective This paper intends to explore the expression and clinical significance of the exchange protein directly activated by cAMP1(Epac1)in gastric cancer tissue.Methods A total of 65 patients who were diagnosed and underwent radical gastrectomy in the Department of Gastrointestinal Surgery at the Affiliated Hospital of Southwest Medical University from January 1,2016 to December 31,2016 were selected and their specimens of gastric cancer tissue,adjacent tissue,and normal tissue were collected.Western blotting was used to detect the expression levels of Epac1 protein in gastric cancer tissues,adjacent tissues,normal tissues,as well as poorly differentiated,moderately differentiated,and well differentiated gastric cancer tissues.Immunohistochemical staining was used to detect the expression of Epac1 in gastric cancer tissue,adjacent tissue,and normal tissue.Based on the expression of Epac1 in gastric cancer tissue,the patients were divided into the Epac1 low expression group and the Epac1 high expression group,and the relationship between different Epac1 expressions and clinical pathological characteristics in gastric cancer tissue was analyzed.Follow up was conducted on 65 gastric cancer patients after surgery,and Kaplan-Meier survival curves were plotted to analyze the relationship between Epac1 expression and prognosis.Results The expression levels of Epac1 protein in gastric cancer tissues are significantly higher than those in adjacent and normal tissues(P<0.01),and the expression levels of Epac1 protein in poorly differentiated gastric cancer tissues are significantly higher than those in moderately and well differentiated gastric cancer tissues(P<0.01).The expression of Epac1 in gastric cancer tissue is correlated with tumor infiltration depth,lymph node metastasis,distant metastasis,vascular invasion,TNM staging,and differentiation degree(P<0.05),but not with patient gender,age,tumor location,tumor diameter,and tumor type(P>0.05).The Kaplan-Meier survival curve analysis shows that the overall survival rate and disease-free survival rate in the Epac1 high expression group are significantly lower than those in the Epac1 low expression group 3 years after surgery(P<0.05).Conclusion The expression of Epac1 is up-regulated in gastric cancer tissues,which is associated with poor prognosis in gastric cancer patients,suggesting that Epac1 may be involved in the occurrence and progression of gastric cancer,and has certain predictive value for the prognosis of gastric cancer patients.
作者 张强 赵正飞 邓洪 ZHANG Qiang;ZHAO Zhengfei;DENG Hong(Department of Gastrointestinal Surgery,the Affiliated Hospital of Southwest Medical University,Luzhou 646000,China)
出处 《国际消化病杂志》 2025年第4期231-236,共6页 International Journal of Digestive Diseases
基金 国家自然科学基金(81901629)。
关键词 环磷酸腺苷活化交换蛋白1 胃癌 预后 Exchange protein directly activated by cAMP1 Gastric cancer Prognosis
  • 相关文献

参考文献5

二级参考文献17

  • 1Muhammed Ashraf Memon,Nick Butler,Breda Memon.The issue of lymphadenectomy during laparoscopic gastrectomy for gastric carcinoma[J].World Journal of Gastrointestinal Oncology,2010,2(2):65-67. 被引量:10
  • 2Wei-guo Zhu,Da-fu Xua,Jun Pu,Cheng-dong Zong,Tao Li,Guang-zhou Tao,Fu-zhi Ji,Xi-lei Zhou,Ji-hua Han,Cheng-shi Wang,Chang-hua Yu,Jiang-guo Yi,Xi-long Su,Jin-xia Ding.A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection[J]. Radiotherapy and Oncology . 2012 (3)
  • 3Mun Ki Choi,Gwang Ha Kim,Do Youn Park,Geun Am Song,Dong Uk Kim,Dong Yup Ryu,Bong Eun Lee,Jae Hoon Cheong,Mong Cho.Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a single-center experience[J]. Surgical Endoscopy . 2013 (11)
  • 4Andrea Coratti,Mario Annecchiarico,Michele Di Marino,Edoardo Gentile,Francesco Coratti,Pier Cristoforo Giulianotti.Robot-assisted Gastrectomy for Gastric Cancer: Current Status and Technical Considerations[J].World Journal of Surgery.2013(12)
  • 5Benjamin Schmidt,Nicole Look-Hong,Ugwuji N. Maduekwe,Kevin Chang,Theodore S. Hong,Eunice L. Kwak,Gregory Y. Lauwers,David W. Rattner,John T. Mullen,Sam S. Yoon.Noncurative Gastrectomy for Gastric Adenocarcinoma Should only be Performed in Highly Selected Patients[J].Annals of Surgical Oncology.2013(11)
  • 6J. Chen,Z. Tang,X. Dong,S. Gao,H. Fang,D. Wu,D. Xiang,S. Zhang.Radiofrequency ablation for liver metastasis from gastric cancer[J].European Journal of Surgical Oncology.2013(7)
  • 7J.A. Ajani,M. Buyse,M. Lichinitser,V. Gorbunova,G. Bodoky,J.Y. Douillard,S. Cascinu,V. Heinemann,R. Zaucha,A. Carrato,D. Ferry,V. Moiseyenko.Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study[J].European Journal of Cancer.2013
  • 8Florian Lordick,Yoon-Koo Kang,Hyun-Cheol Chung,Pamela Salman,Sang Cheul Oh,Gy?rgy Bodoky,Galina Kurteva,Constantin Volovat,Vladimir M Moiseyenko,Vera Gorbunova,Joon Oh Park,Akira Sawaki,Ilhan Celik,Heiko G?tte,Helena Melezínková,Markus Moehler.Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial[J].Lancet Oncology.2013(6)
  • 9Lei Jiang,Ke‐Hu Yang,Quan‐Lin Guan,Peng Zhao,Yan Chen,Jin‐Hui Tian.Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: A meta‐analysis[J].J Surg Oncol.2013(8)
  • 10Atsushi Nashimoto,Kohei Akazawa,Yoh Isobe,Isao Miyashiro,Hitoshi Katai,Yasuhiro Kodera,Shunichi Tsujitani,Yasuyuki Seto,Hiroshi Furukawa,Ichiro Oda,Hiroyuki Ono,Satoshi Tanabe,Michio Kaminishi.Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry[J].Gastric Cancer.2013(1)

共引文献189

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部